Patent directory · USPTO A61K / A61P
Patents matching “Karyopharm Therapeutics Inc.”
38 pharma patents match "Karyopharm Therapeutics Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 38 pharmaceutical patents matching "Karyopharm Therapeutics Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12371420
Polymorphs of Selinexor
granted -
US 12331040
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
granted -
US 12318386
Combination of XPO1 inhibitors and second agents for the treatment of prostate cancer
granted -
US 12291508
Hydrazide containing nuclear transport modulators and uses thereof
granted -
US 11945794
Nuclear transport modulators and uses thereof
granted -
US 11807629
Polymorphs of Selinexor
granted -
US 11787771
Hydrazide containing nuclear transport modulators and uses thereof
granted -
US 11753401
Polymorphs of Selinexor
granted -
US 11746102
Polymorphs of selinexor
granted -
US 11124493
Nuclear transport modulators and uses thereof
granted -
US 11078190
Polymorphs of selinexor
granted -
US 11034660
Hydrazide containing nuclear transport modulators and uses thereof
granted -
US 11008309
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
granted -
US 10858347
Multicyclic compounds and uses thereof
granted -
US 10544108
Hydrazide containing nuclear transport modulators and uses thereof
granted -
US 10526295
Nuclear transport modulators and uses thereof
granted -
US 10519139
Polymorphs of Selinexor
granted -
US 10407405
Nuclear transport modulators and uses thereof
granted -
US 10399963
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
granted -
US 10363247
(S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer
granted -
US 10202366
Methods of promoting wound healing using CRM1 inhibitors
granted -
US 10173987
Hydrazide containing nuclear transport modulators and uses thereof
granted -
US 9994558
Multicyclic compounds and methods of using same
granted -
US 9938258
Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
granted